Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FANG(30) in Active Rheumatoid Arthritis
NCT00749645Phase 2Completed
- Start
- Oct 2006
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of andrographolide in rheumatoid arthritis (RA). Started Oct 2006; status: completed.
02
Drugs
andrographolide
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00749645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00749645.